Identification and characterization of novel antibody biomarkers after spinal cord injury

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON23009

Enrollment

Registered

2013-11-18

Start date

2013-12-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal cord injury, Biomarker Ruggenmergschade, Biomerker

Interventions

An additional tube of blood is collected during a standard blood test together with clinical information relevant for the study.

Eligibility

Inclusion criteria

Inclusion criteria: All traumatic and pathological spinal cord injury patients can be included in this study (> 18 years both male and female).

Exclusion criteria

Exclusion criteria: The exclusion criteria of this study is the presence of pre-existing autoimmune disorders.

Design outcomes

Primary

Measure	Time frame
The primary outcome of this study is to identify a panel of candidate biomarkers in spinal cord injury pathology.	—

Secondary

Measure	Time frame
The secondary outcome of this study is to characterize the identified candidate biomarkers for their relevance in spinal cord injury pathology.	—

Contacts

Public ContactVeerle Somers

Biomedical Research Institute Hasselt University

veerle.somers@uhasselt.be+32 11269202

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)